10-Q
Quarterly Report
ACRO BIOMEDICAL CO., LTD.
CIK: 1622996
File #: 000-55643
Balance Sheet
30 line items · 2 periods
XBRL
| Item | Sep 30, 2024 | Dec 31, 2023 |
|---|---|---|
Balance Sheets | ||
ASSETS | ||
Current Assets | ||
Cash | 701 | 376 |
Other Non-Operating Current Assets | 0 | 1,250 |
Total Current Assets | 701 | 1,626 |
Operating Lease Right-of-Use Asset | 33,375 | 52,233 |
Other Non-Operating Current Assets | 4,600 | 4,600 |
TOTAL ASSETS | 38,676 | 58,459 |
LIABILITIES AND STOCKHOLDERS' DEFICIT | ||
Current Liabilities | ||
Accounts Payable | 155,507 | 154,444 |
Other Current Liabilities | 20,000 | 20,000 |
Due to related parties | 115,298 | 88,796 |
CEO | 1,100 | 1,100 |
Operating Lease Liability, Current | 26,499 | 25,335 |
Total Current Liabilities | 317,304 | 288,575 |
Operating Lease Liability, Non-Current | 6,876 | 26,898 |
TOTAL LIABILITIES | 324,180 | 315,473 |
Stockholders' Deficit | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 60,042 | 60,042 |
Total Stockholders' Equity | 32,301,576 | 32,298,442 |
Total Stockholders' Equity | (32,647,122) | (32,615,498) |
Total Stockholders' Deficit | (285,504) | (257,014) |
Accumulated Deficit | (32,647,122) | (32,615,498) |
Additional Paid-In Capital | 32,301,576 | 32,298,442 |
Common Stock | 60,042 | 60,042 |
Preferred Stock | 0 | 0 |
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | 38,676 | 58,459 |